Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.

Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study. Am Heart J. 2012 Mar; 163(3):515-21, 521.e1-3.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Amides
Anticholesteremic Agents
Dose-Response Relationship, Drug
Double-Blind Method
Drug Therapy, Combination
Dyslipidemias
Electrophoresis, Polyacrylamide Gel
Esters
Female
Follow-Up Studies
Humans
Lipoproteins, HDL
Magnetic Resonance Spectroscopy
Male
Middle Aged
Pravastatin
Sulfhydryl Compounds
Treatment Outcome
Young Adult